2020 跨業整合生醫躍進專案計畫 成果發表

Home|News release|Company Progress|2020 跨業整合生醫躍進專案計畫 成果發表
  • 光宇生醫參與2020創新醫材新趨勢暨產學合作成果發表會並且發表由國內科技部支持研發的[高複雜人工耳殼植入式產品設計開發與臨床服務流程],從本公司研發的高分子複合材料及醫療等級的高階植入式醫材積層製造技術,結合臨床數位製造,從合作夥伴醫院端快速且正確導入客製化設計,並經由國際需求之醫療器材驗證場域與動物模型驗證,縮短臨床需求導入實際產品商業化之鴻溝,有效串聯醫院與產品開發端之資源,經由優化後的積層製造機台,快速將臨床需求轉譯成產品規格,以縮短產品上市之時程。 ABT announce the 2019 New RD project accomplishment. In this project granted from Taiwan MOST (2019-2020), a smart medical device AM manufacturing system for customized microtia is developed for patients who suffered from appearance asymmetry. Both biomaterials and manufacturing systems of the with mechanics, biodegradability and biocompatibility properties are also investigated. Upon medical image (DICOM) input from clinical image center, we integrates whole medical device R&D pipeline from image working flow, materials selection and post processing. Based on our patented core technologies, with proprietary additively manufacturing machines , we verified with artificial auricle implant with animal model testing and commercialization process.

光宇生醫科技獲外媒評選為2019年亞太區10大新創生技企業。

光宇生醫科技獲外媒評選為2019年亞太區10大新創生技企業。

By |October 10th, 2019|Categories: Company Progress, News release|Comments Off on 光宇生醫科技獲外媒評選為2019年亞太區10大新創生技企業。

Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)

Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)

By |July 12th, 2019|Categories: Company Progress, News release|Comments Off on Advanced Biomedical Technology awarded Taiwan Government Grant (FY2019-2020)

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

By |May 6th, 2019|Categories: Company Progress, News release|Comments Off on Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.

2021, 3/24-3/25 臺英積層製造虛實整合交流會議

光宇生醫 很高興受邀參加英國在台協會與工研院所舉辦的臺英積層製造虛實整合交流會議,時間在3/24與3/25的下午四點,我們預計會在第二天週四下午進行15分鐘的簡介與討論,歡迎有興趣者上網報名加入線上會議(線上免費會議)。 會議連結如下https://3dprintingonlineforum.godaddysites.com/ On Thursday afternoon, we are very exciting

By |March 22nd, 2021|Categories: Media Exposure, News release|Comments Off on 2021, 3/24-3/25 臺英積層製造虛實整合交流會議
  • 光宇生醫參與 新竹竹科管理局 12/2舉辦「2020疫後新視界.眺望ICT商機」與研發精進成果展出。光宇生醫研製之高精密變速溫控系統於積層製造列印關鍵模組,歡迎大家參與會議討論。 ABT announced the new IOT embedded extruder for medical 3D printing application . This RPCP project is granted from Hsinchu science park from 2019.5-2020.5.

2020 研發精進產學合作計畫 期末發表會

By |December 2nd, 2020|Categories: Company Progress, News release|Comments Off on 2020 研發精進產學合作計畫 期末發表會
  • 光宇生醫參與2020創新醫材新趨勢暨產學合作成果發表會並且發表由國內科技部支持研發的[高複雜人工耳殼植入式產品設計開發與臨床服務流程],從本公司研發的高分子複合材料及醫療等級的高階植入式醫材積層製造技術,結合臨床數位製造,從合作夥伴醫院端快速且正確導入客製化設計,並經由國際需求之醫療器材驗證場域與動物模型驗證,縮短臨床需求導入實際產品商業化之鴻溝,有效串聯醫院與產品開發端之資源,經由優化後的積層製造機台,快速將臨床需求轉譯成產品規格,以縮短產品上市之時程。 ABT announce the 2019 New RD project accomplishment. In this project granted from Taiwan MOST (2019-2020), a smart medical device AM manufacturing system for customized microtia is developed for patients who suffered from appearance asymmetry. Both biomaterials and manufacturing systems of the with mechanics, biodegradability and biocompatibility properties are also investigated. Upon medical image (DICOM) input from clinical image center, we integrates whole medical device R&D pipeline from image working flow, materials selection and post processing. Based on our patented core technologies, with proprietary additively manufacturing machines , we verified with artificial auricle implant with animal model testing and commercialization process.

2020 跨業整合生醫躍進專案計畫 成果發表

By |November 30th, 2020|Categories: Company Progress, News release|Comments Off on 2020 跨業整合生醫躍進專案計畫 成果發表

2020 12/3-12/6 醫療科技展 創新技術特展 Taiwan Healthcare+ InnoZone

光宇生醫將參加2020醫療科技展,InnoZone創新技術特展 本公司所推出之產品MeDFila®為已獲准美國FDA原料主檔案MAF建立之醫療級原料,透過高分子材料PCL/PLGA與不同比例陶瓷混合製成之線材,可應用在3D列印生醫應用的不同領域中,包括牙科、植入物、醫療零件、藥物篩選、組織工程等應用。除了線材外,本公司也同步與臨床醫院進行合作,透過本公司研發的高分子複合材料及醫療等級的高階植入式醫材積層製造技術,結合臨床數位影像建模製造,從醫院端快速且正確導入客製化設計。 Advanced Biomedical Technology attend Taiwan Healthcare+ InnoZone

By |November 22nd, 2020|Categories: Events, Events|Comments Off on 2020 12/3-12/6 醫療科技展 創新技術特展 Taiwan Healthcare+ InnoZone
By |2020-12-02T22:46:15+08:00November 30th, 2020|Company Progress, News release|Comments Off on 2020 跨業整合生醫躍進專案計畫 成果發表

About the Author:

Go to Top